ChemicalBook > CAS DataBase List > Ixekizumab

Ixekizumab

Product Name
Ixekizumab
CAS No.
1143503-69-8
Chemical Name
Ixekizumab
Synonyms
LY2439821;Ixekizumab;Ixekizumab (anti-CTLA-8);Research Grade Ixekizumab;Research Grade Ixekizumab(DHH28801)
CBNumber
CB24845997
Molecular Formula
N/A
Formula Weight
0
MOL File
Mol file
More
Less

Ixekizumab Property

storage temp. 
Store at 4°C, do not freeze
form 
Liquid
color 
Colorless to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Ixekizumab Chemical Properties,Usage,Production

Description

Ixekizumab (Taltz) is a biologic medication used to treat psoriatic arthritis, plaque psoriasis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Biologic medications are proteins designed by humans that affect the immune system. Ixekizumab blocks the inflammatory protein IL-17A. This improves joint pain and swelling from arthritis and rash in psoriatic conditions.

Uses

Ixekizumab (LY2439821) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD<3 pM). Ixekizumab directly blocks IL-17A binding to IL-17RA (IL-17A receptor) but does not bind to other IL-17 family members. Ixekizumab is used for the research of moderate-to-severe plaque psoriasis[1][2].

Indications

Ixekizumab is FDA-indicated for the adult treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, active ankylosing spondylitis, and active non-radiographic axial spondyloarthritis with objective signs of inflammation.

Side effects

Ixekizumab can lower the ability of your immune system to fight infections. If you develop symptoms of an infection while using this medication, you should stop it and contact your rheumatology provider. All patients should be tested for tuberculosis and hepatitis before starting on ixekizumab. The most common side effects are infections, injection site reactions, upper respiratory infections, and lowering of white blood cells called neutropenia. Rare cases of inflammatory bowel disease (Crohn’s disease or ulcerative colitis) have been seen. Ixekizumab has not been studied in pregnancy or breastfeeding.

in vivo

Ixekizumab (0.001-1 mg/kg; i.v.) is able to decrease human IL-17A-induced keratinocyte chemoattractant (KC) secretion in the plasma of the C57BL/6 mice in a dose-dependent manner[1].
In male cynomolgus monkeys, following IV administration of 1 mg/kg, Ixekizumab is eliminated with a mean half-life of 6.5 days. After SC administration of 1 mg/kg, Ixekizumab reaches an average maximal plasma concentration of 11.1 μg/mL ~72 hours postdose. The mean elimination half-life following the SC injection was 10.3 days[1].

Animal Model:C57BL/6 mice (n=5 per group, 8-12-week old, subcutaneous injection of human IL-17A)[1]
Dosage:1 mg/kg, 0.1 mg/kg, 0.01 mg/kg, or 0.001 mg/kg (corresponding to 20 μg, 2 μg, 0.2 μg, and 0.02 μg per mouse, respectively)
Administration:I.v.; 1 hour prior to a subcutaneous (SC) injection of human IL-17A
Result:Decrease human IL-17A-induced KC secretion in the plasma of the C57BL/6 mice in a dose-dependent manner.

IC 50

IL-17

References

[1] G. AVALLONE. Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis[J]. Journal of the European Academy of Dermatology and Venereology, 2022, 36 7: e574-e576. DOI:10.1111/jdv.18069.
[2] A. PALLER. Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis[J]. JAMA dermatology, 2022, 158 1: 533-541. DOI:10.1001/jamadermatol.2022.0655.
[3] https://rheumatology.org/patients/ixekizumab-taltz
[4] https://www.ncbi.nlm.nih.gov/books/NBK431088/

Ixekizumab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Ixekizumab Suppliers

Wuhan Sunrise Technology Development Co., Ltd.
Tel
27-027-83314682 13554138826
Fax
+86 (27) 8331-4682
Email
whsrtech@vip.163.com
Country
China
ProdList
246
Advantage
62
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9803
Advantage
58
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
71826
Advantage
60
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
Guangzhou Hongyuan Chemical Co.,Ltd
Tel
15817493340
Email
981810490@qq.com
Country
China
ProdList
1566
Advantage
58
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Fax
QQ:422450190
Email
422450190@qq.com
Country
China
ProdList
10308
Advantage
58
Hubei Kele Fine Chemical Co., Ltd
Tel
027-59101668 19945030958
Fax
027-59101668
Email
2881924765@qq.com
Country
China
ProdList
7937
Advantage
58
Wuhan Yingnuo Pharmaceutical Technology Co., Ltd.
Tel
15387063101
Email
2881924050@qq.com
Country
China
ProdList
9958
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24961
Advantage
58
Biolab Reagents
Tel
027-65279366 18108604356
Email
products@biolabreagent.com
Country
China
ProdList
9868
Advantage
58
Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel
13720134139 086-15871494362 13720134139
Email
orders@jknbiochem.com
Country
China
ProdList
6762
Advantage
58
Shanghai Aladdin Biochemical Technology Co.,Ltd.
Tel
400-6206333 13167063860
Email
anhua.mao@aladdin-e.com
Country
China
ProdList
48457
Advantage
58
Changsha Fuzhen Biotechnology Co.,LTD
Tel
0731-13823398 15111215862
Email
313359644@qq.com
Country
China
ProdList
4161
Advantage
58
Wanxin Biotechnology (Jiaxing) Co., LTD
Tel
0573-83568680 18057391398
Email
3956524501@qq.com
Country
China
ProdList
1442
Advantage
58
Atagenix Laboratories
Tel
027-87008169 17762441161
Email
info@atagenix.com
Country
China
ProdList
10001
Advantage
58
Sangon Biotech (Shanghai) Co.,Ltd.
Tel
400-821-026
Email
Sales@sangon.com
Country
China
ProdList
6710
Advantage
58
Aikon International Limited
Tel
025-58851090 13408877820
Email
2850281427@qq.com
Country
China
ProdList
10000
Advantage
58
AntibodySystem Laboratories SAS
Tel
33175446423
Email
support@antibodysystem.com
Country
China
ProdList
6739
Advantage
58
Biosynth Biological Technology (Suzhou) Co Ltd
Tel
51288865780
Email
sales@biosynth.com
Country
China
ProdList
6051
Advantage
58
Cell Sciences
Tel
9785721070
Email
info@cellsciences.com
Country
China
ProdList
6308
Advantage
58
BioEasy Biotech (Shenzhen) Co., Ltd.
Tel
18666024416
Country
CHINA
ProdList
185
Advantage
58
Guangzhou Taozhu Biotechnology Co., Ltd
Tel
4008200310
Country
CHINA
ProdList
111
Advantage
58
Guangzhou Chuangze Biotechnology Co., Ltd.
Tel
18312220236
Country
CHINA
ProdList
178
Advantage
58
Proteintech China
Tel
--
Fax
--
Email
Proteintech-CN@ptglab.com
Country
CHINA
ProdList
6290
Advantage
58

1143503-69-8, IxekizumabRelated Search:


  • Ixekizumab
  • Research Grade Ixekizumab(DHH28801)
  • Ixekizumab (anti-CTLA-8)
  • LY2439821
  • Research Grade Ixekizumab
  • 1143503-69-8